AM-F9
Alternative Names: Anti-mimotope antiserum-F9; BCD-F9; Monoclonal antibody BCD-F9Latest Information Update: 15 Apr 2004
At a glance
- Originator Biophage Pharma; Supratek Pharma; University of Quebec
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer